longbridge

Nurix Therapeutics

NRIX
----

All Shareholders

Shareholder Type

  • Institutions75.18%
  • Hedge funds12.78%
  • VC/PE firms11.10%
  • Individuals & Insiders0.81%
  • Private companies0.13%

Major Shareholders

Major Shareholders Latest
Shareholder
BlackRock, Inc.
8.45%8.77M0.18%-155.29K
Vestal Point Capital, LP
7.76%8.05M1.47%+1.55M
Deep Track Capital, LP
7.45%7.74M1.32%+1.39M
Rubric Capital Management LP
6.96%7.23M4.57%+4.75M
Perceptive Advisors LLC
5.33%5.54M1.17%+1.22M
FMR LLC
5.28%5.48M0.07%-55.91K
T. Rowe Price Group, Inc.
5.24%5.44M2.06%+2.15M
Vanguard Capital Management, LLC
4.99%5.18M0.10%+122.52K
Morgan Stanley
4.53%4.70M0.19%-183.61K
State Street Investment Management
4.51%4.68M0.47%-463.95K
Baker Bros. Advisors LP
4.49%4.66M0.02%+0
Redmile Group, LLC
3.93%4.07M3.55%-3.66M
General Atlantic Service Company, L.P.
2.92%3.03M1.05%-1.07M
Geode Capital Management, LLC
2.44%2.54M<0.01%+17.06K
Pictet Asset Management Limited
2.27%2.35M0.37%-374.91K
ARK Investment Management LLC
1.73%1.79M0.06%+72.06K
Capital Research and Management Company
1.72%1.79M0.86%+894.59K
Trails Edge Capital Partners, LP
1.52%1.57M0.17%-170.00K
Vanguard Portfolio Management, LLC
1.43%1.48M0.36%+380.60K
Citadel Advisors LLC
1.42%1.48M0.12%+133.32K
© 2026 Longbridge｜Terms of ServicePrivacy Policy